227 related articles for article (PubMed ID: 29981039)
1. Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.
Young S; Fairbairn N
Can J Public Health; 2018 Apr; 109(2):227-230. PubMed ID: 29981039
[TBL] [Abstract][Full Text] [Related]
2. Supervised injection facilities in Canada: past, present, and future.
Kerr T; Mitra S; Kennedy MC; McNeil R
Harm Reduct J; 2017 May; 14(1):28. PubMed ID: 28521829
[TBL] [Abstract][Full Text] [Related]
3. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.
Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR
J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
[TBL] [Abstract][Full Text] [Related]
5. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
6. Use of on-site detoxification services co-located with a supervised injection facility.
Gaddis A; Kennedy MC; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T
J Subst Abuse Treat; 2017 Nov; 82():1-6. PubMed ID: 29021106
[TBL] [Abstract][Full Text] [Related]
7. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.
Irwin A; Jozaghi E; Weir BW; Allen ST; Lindsay A; Sherman SG
Harm Reduct J; 2017 May; 14(1):29. PubMed ID: 28532488
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.
Wolfson-Stofko B; Elliott L; Bennett AS; Curtis R; Gwadz M
Int J Drug Policy; 2018 Dec; 62():67-73. PubMed ID: 30359875
[TBL] [Abstract][Full Text] [Related]
9. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
[TBL] [Abstract][Full Text] [Related]
10. Opening Canada's first Health Canada-approved supervised consumption sites.
Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
[TBL] [Abstract][Full Text] [Related]
11. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
[TBL] [Abstract][Full Text] [Related]
12. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
[TBL] [Abstract][Full Text] [Related]
13. Increasing public support for supervised injection facilities in Ontario, Canada.
Strike C; Jairam JA; Kolla G; Millson P; Shepherd S; Fischer B; Watson TM; Bayoumi AM
Addiction; 2014 Jun; 109(6):946-53. PubMed ID: 24520984
[TBL] [Abstract][Full Text] [Related]
14. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE; Richardson J; Frasso R; Anderson ED
Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
[TBL] [Abstract][Full Text] [Related]
15. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
Hyshka E; Bubela T; Wild TC
Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
[TBL] [Abstract][Full Text] [Related]
16. Supervised Injection Facilities as Harm Reduction: A Systematic Review.
Levengood TW; Yoon GH; Davoust MJ; Ogden SN; Marshall BDL; Cahill SR; Bazzi AR
Am J Prev Med; 2021 Nov; 61(5):738-749. PubMed ID: 34218964
[TBL] [Abstract][Full Text] [Related]
17. IDU perspectives on the design and operation of North America's first medically supervised injection facility.
Small W; Ainsworth L; Wood E; Kerr T
Subst Use Misuse; 2011; 46(5):561-8. PubMed ID: 20874006
[TBL] [Abstract][Full Text] [Related]
18. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
Notta D; Black B; Chu T; Joe R; Lysyshyn M
Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
[TBL] [Abstract][Full Text] [Related]
19. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.
Boyd J; Collins AB; Mayer S; Maher L; Kerr T; McNeil R
Addiction; 2018 Dec; 113(12):2261-2270. PubMed ID: 30211453
[TBL] [Abstract][Full Text] [Related]
20. Ambivalence about supervised injection facilities among community stakeholders.
Strike C; Watson TM; Kolla G; Penn R; Bayoumi AM
Harm Reduct J; 2015 Aug; 12():26. PubMed ID: 26292715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
